Fortress Biotech ROCE 2024

Fortress Biotech Aktienanalyse

What does Fortress Biotech do?

Fortress Biotech Inc was founded in 2006 and is headquartered in New York City. The company specializes in the development of therapies for serious diseases and operates under a cooperative business model. The business model of Fortress Biotech is based on having multiple subsidiary companies under its umbrella, each focusing on specific development programs. This allows for specialized coverage of every aspect of the development process, from basic research to clinical trials to drug approval by authorities, by each subsidiary. Fortress Biotech has a total of nine subsidiary companies, each conducting its own research and development programs. These programs mainly target cancer, rare diseases, and metabolic disorders. With its various subsidiary companies, the company is able to develop and manufacture a wide range of therapeutic solutions. One of Fortress Biotech's most well-known subsidiary companies is Mustang Bio, a biotechnology company focusing on the development of immune-based therapies for cancer patients. The company has developed a promising CAR-T cell therapy that is currently being studied in clinical trials. Another subsidiary company of Fortress Biotech is Caelum Biosciences, which develops therapies for hematological diseases. The company is currently working on a promising monoclonal antibody therapy to help patients with the rare disease AL amyloidosis. In addition to its subsidiary companies, Fortress Biotech also collaborates with other companies and academic institutions to develop innovative therapies. The company has partnerships with companies such as Kadmon Holdings, Inc. and Aevi Genomic Medicine, Inc. Fortress Biotech has had an impressive growth story in recent years. Through targeted acquisitions of companies with promising product pipelines, the company has been able to rapidly progress and expand its offering of therapeutic solutions. In summary, Fortress Biotech is a promising biotechnology company specializing in the development of therapies for serious diseases. With its cooperative business model, wide range of subsidiary companies, and partnerships, the company is able to develop and bring innovative therapy solutions to market to help patients worldwide. Fortress Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Fortress Biotech's Return on Capital Employed (ROCE)

Fortress Biotech's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Fortress Biotech's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Fortress Biotech's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Fortress Biotech’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Fortress Biotech stock

What is the ROCE (Return on Capital Employed) of Fortress Biotech this year?

The ROCE of Fortress Biotech is -6.18 undefined this year.

How has the ROCE (Return on Capital Employed) of Fortress Biotech developed compared to the previous year?

The ROCE of Fortress Biotech has increased by 26.53% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Fortress Biotech?

A high Return on Capital Employed (ROCE) indicates that Fortress Biotech has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Fortress Biotech?

A low ROCE (Return on Capital Employed) can indicate that Fortress Biotech has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Fortress Biotech impact the company?

An increase in the ROCE of Fortress Biotech can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Fortress Biotech affect the company?

A decrease in ROCE of Fortress Biotech can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Fortress Biotech?

Some factors that can affect Fortress Biotech's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Fortress Biotech so important for investors?

The ROCE of Fortress Biotech is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Fortress Biotech take to improve the ROCE?

To improve the ROCE, Fortress Biotech can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Fortress Biotech pay?

Over the past 12 months, Fortress Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fortress Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Fortress Biotech?

The current dividend yield of Fortress Biotech is .

When does Fortress Biotech pay dividends?

Fortress Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fortress Biotech?

Fortress Biotech paid dividends every year for the past 0 years.

What is the dividend of Fortress Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fortress Biotech located?

Fortress Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fortress Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fortress Biotech from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Fortress Biotech pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Fortress Biotech in the year 2023?

In the year 2023, Fortress Biotech distributed 0 USD as dividends.

In which currency does Fortress Biotech pay out the dividend?

The dividends of Fortress Biotech are distributed in USD.